miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer

Our previous study found that miR-145 was downregulated in non-small cell lung cancer (NSCLC) tissues and that it could inhibit the cell proliferation in transfected NSCLC cells. In this study, we found that miR-145 was downregulated in NSCLC plasma samples compared to healthy controls. A receiver o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, William C., Wong, Chi F., Li, Kwan P., Fong, Alvin H., Fung, King Y., Au, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298104/
https://www.ncbi.nlm.nih.gov/pubmed/37373169
http://dx.doi.org/10.3390/ijms241210022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298104/
https://www.ncbi.nlm.nih.gov/pubmed/37373169
http://dx.doi.org/10.3390/ijms241210022

Ejemplares similares